Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00773942 · ClinicalTrials.gov registry record · NA
Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 637
- Enrollment target
NCT00773942: Completed NA study, sponsored by University of Illinois at Chicago.
NCT00773942 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 637 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00773942, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 637 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a medication therapy management program designed to reconcile a patient's medications and identify and resolve drug related problems can reduce adverse drug events and other measures of safety and improve patient satisfaction.
Primary Outcome
ADEs will be assessed via patient telephone interview using a tool modified from Jarernsiripornkul et al
Interventions
- BEHAVIORAL Basic medication therapy management
- BEHAVIORAL Enhanced medication therapy management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 637 participants |
| Start Date | 2007-11 |
| Est. Completion | 2010-01 |
| Phase | NA |
What the finished NCT00773942 record still lists
NCT00773942 is an interventional study that assigns participants to a tested intervention. The registered 637 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which Basic medication therapy management is the first listed.
NCT00773942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00773942 about?
NCT00773942 is a clinical study titled "Design & Evaluation of a Medication Therapy Management Program to Improve Patient Safety in Medicare Beneficiaries". The purpose of this study is to determine if a medication therapy management program designed to reconcile a patient's medications and identify and resolve drug related problems can reduce adverse drug events and other measures of safety and improve patient satisfaction.
What is the current status of trial NCT00773942?
This trial is currently completed. It is a NA study. The enrollment target is 637 participants. The study started on 2007-11. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00773942?
The interventions under investigation include: Basic medication therapy management (BEHAVIORAL), Enhanced medication therapy management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00773942?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00773942's enrollment target sits among peer trials
637 157th of 2000 higher than 1,844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821129 · 636 participants · NA
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia